Search

Your search keyword '"Li, Wen-Hui"' showing total 195 results

Search Constraints

Start Over You searched for: Author "Li, Wen-Hui" Remove constraint Author: "Li, Wen-Hui" Publication Year Range Last 3 years Remove constraint Publication Year Range: Last 3 years
195 results on '"Li, Wen-Hui"'

Search Results

5. Transarterial chemoembolization with PD-(L)1 inhibitors plus molecular targeted therapies for hepatocellular carcinoma (CHANCE001)

6. Update on the genetic diversity and population structure of Echinococcus granulosus in Gansu Province, Tibet Autonomous Region, and Xinjiang Uygur Autonomous Region, Western China, inferred from mitochondrial cox1, nad1, and nad5 sequences

18. Essential oils as therapeutic and protective instruments in depression based on animal models: A systematic review and meta-analysis

19. Multi-Task Spatial-Temporal Transformer for Multi-Variable Meteorological Forecasting

20. NH4Ca[B5O7(OH)4] H2O: A Biaxial Mixed‐Cation Pentaborate with Moderate Birefringence.

26. Seismic Reflection Profiling Reveals New Accretionary Structure in the Solonker Zone of the Central Asian Orogenic Belt.

27. A new genus, Sinodromus gen. nov., with two new species and the first description of the female of Philodromus guiyang Long & Yu, 2022 (Arachnida, Araneae, Philodromidae) from China.

28. Screening and characterization of bacteriostatic Bacillus.

29. Myopia: Its Status and Environmental Correlations Among School Students in Fushun, China.

34. Data from Characterization of a Novel Mitogen-Activated Protein Kinase Kinase 1/2 Inhibitor with a Unique Mechanism of Action for Cancer Therapy

35. Supplementary Table 2 from Characterization of a Novel Mitogen-Activated Protein Kinase Kinase 1/2 Inhibitor with a Unique Mechanism of Action for Cancer Therapy

36. Supplementary Figures 1-2 from Identification of the MEK1(F129L) Activating Mutation as a Potential Mechanism of Acquired Resistance to MEK Inhibition in Human Cancers Carrying the B-RafV600E Mutation

37. Supplementary Table Legends 1-2 from Characterization of a Novel Mitogen-Activated Protein Kinase Kinase 1/2 Inhibitor with a Unique Mechanism of Action for Cancer Therapy

38. Supplementary Figure Legends 1-2 from Identification of the MEK1(F129L) Activating Mutation as a Potential Mechanism of Acquired Resistance to MEK Inhibition in Human Cancers Carrying the B-RafV600E Mutation

39. Data from Identification of the MEK1(F129L) Activating Mutation as a Potential Mechanism of Acquired Resistance to MEK Inhibition in Human Cancers Carrying the B-RafV600E Mutation

40. Supplementary Table 1 from Characterization of a Novel Mitogen-Activated Protein Kinase Kinase 1/2 Inhibitor with a Unique Mechanism of Action for Cancer Therapy

Catalog

Books, media, physical & digital resources